MovDisordV3, PascalFrancis, Curation, bibRecord, 001037

Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections

Identifieur interne : 001037 ( PascalFrancis/Curation ); précédent : 001036; suivant : 001038

Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections

Auteurs : Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni]

Source :

Movement disorders [ 0885-3185 ] ; 2006.

RBID : Pascal:06-0135498

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Excitabilité, Homme, Spasme, Traitement, Bontoxilysin, Réflexe palpébral.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Bontoxilysin, Excitability, Human, Nervous system diseases, Palpebral reflex, Spasm, Treatment.

Abstract

Hemimasticatory spasm (HMS) is a condition characterized by paroxysmal involuntary contraction of masticatory muscles. We performed an electrophysiological investigation of a single patient with HMS to identify any pathophysiological changes associated with the condition. We identified a delayed M wave and jaw jerk on the affected side and an absent masseteric silent period during spasm. Botulinum toxin injections successfully treated the clinical symptoms and resulted in a significant reduction in the excitability of the blink reflex recovery cycle. These data suggest that HMS may be due to ectopic activity in the motor portion of the trigeminal nerve that is capable of inducing changes in the excitability of central reflex pathways. These changes can be altered by successful treatment with botulinum toxin.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 21`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections`
A11	`01`	`1`		`@1 MIR (Pablo)`
A11	`02`	`1`		`@1 GILIO (Francesca)`
A11	`03`	`1`		`@1 EDWARDS (Mark)`
A11	`04`	`1`		`@1 INGHILLERI (Maurizio)`
A11	`05`	`1`		`@1 BHATIA (Kailash P.)`
A11	`06`	`1`		`@1 ROTHWELL (John C.)`
A11	`07`	`1`		`@1 QUINN (Niall)`
A14	`01`			`@1 Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square @2 London @3 GBR @Z 1 aut. @Z 3 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.`
A14	`02`			`@1 Servicio de Neurología, Hospital Universitario Virgen del Rocio @2 Seville @3 ESP @Z 1 aut.`
A14	`03`			`@1 Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS @2 Pozzilli, IS @3 ITA @Z 2 aut. @Z 4 aut.`
A20				`@1 73-78`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000133169150120`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 24 ref.`
A47	`01`	`1`		`@0 06-0135498`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Hemimasticatory spasm (HMS) is a condition characterized by paroxysmal involuntary contraction of masticatory muscles. We performed an electrophysiological investigation of a single patient with HMS to identify any pathophysiological changes associated with the condition. We identified a delayed M wave and jaw jerk on the affected side and an absent masseteric silent period during spasm. Botulinum toxin injections successfully treated the clinical symptoms and resulted in a significant reduction in the excitability of the blink reflex recovery cycle. These data suggest that HMS may be due to ectopic activity in the motor portion of the trigeminal nerve that is capable of inducing changes in the excitability of central reflex pathways. These changes can be altered by successful treatment with botulinum toxin.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B02C`
C02	`03`	`X`		`@0 002B17F`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Excitabilité @5 09`
C03	`02`	`X`	`ENG`	`@0 Excitability @5 09`
C03	`02`	`X`	`SPA`	`@0 Excitabilidad @5 09`
C03	`03`	`X`	`FRE`	`@0 Homme @5 10`
C03	`03`	`X`	`ENG`	`@0 Human @5 10`
C03	`03`	`X`	`SPA`	`@0 Hombre @5 10`
C03	`04`	`X`	`FRE`	`@0 Spasme @5 11`
C03	`04`	`X`	`ENG`	`@0 Spasm @5 11`
C03	`04`	`X`	`SPA`	`@0 Espasmo @5 11`
C03	`05`	`X`	`FRE`	`@0 Traitement @5 12`
C03	`05`	`X`	`ENG`	`@0 Treatment @5 12`
C03	`05`	`X`	`SPA`	`@0 Tratamiento @5 12`
C03	`06`	`X`	`FRE`	`@0 Bontoxilysin @2 FE @2 FR @5 13`
C03	`06`	`X`	`ENG`	`@0 Bontoxilysin @2 FE @2 FR @5 13`
C03	`06`	`X`	`SPA`	`@0 Bontoxilysin @2 FE @2 FR @5 13`
C03	`07`	`X`	`FRE`	`@0 Réflexe palpébral @5 14`
C03	`07`	`X`	`ENG`	`@0 Palpebral reflex @5 14`
C03	`07`	`X`	`SPA`	`@0 Reflejo palpebral @5 14`
C07	`01`	`X`	`FRE`	`@0 Metalloendopeptidases @2 FE`
C07	`01`	`X`	`ENG`	`@0 Metalloendopeptidases @2 FE`
C07	`01`	`X`	`SPA`	`@0 Metalloendopeptidases @2 FE`
C07	`02`	`X`	`FRE`	`@0 Peptidases @2 FE`
C07	`02`	`X`	`ENG`	`@0 Peptidases @2 FE`
C07	`02`	`X`	`SPA`	`@0 Peptidases @2 FE`
C07	`03`	`X`	`FRE`	`@0 Hydrolases @2 FE`
C07	`03`	`X`	`ENG`	`@0 Hydrolases @2 FE`
C07	`03`	`X`	`SPA`	`@0 Hydrolases @2 FE`
C07	`04`	`X`	`FRE`	`@0 Enzyme @2 FE`
C07	`04`	`X`	`ENG`	`@0 Enzyme @2 FE`
C07	`04`	`X`	`SPA`	`@0 Enzima @2 FE`
N21				`@1 086`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C84

Links to Exploration step

Pascal:06-0135498

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections</title>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Servicio de Neurología, Hospital Universitario Virgen del Rocio</s1>
<s2>Seville</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Gilio, Francesca" sort="Gilio, Francesca" uniqKey="Gilio F" first="Francesca" last="Gilio">Francesca Gilio</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS</s1>
<s2>Pozzilli, IS</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Edwards, Mark" sort="Edwards, Mark" uniqKey="Edwards M" first="Mark" last="Edwards">Mark Edwards</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Inghilleri, Maurizio" sort="Inghilleri, Maurizio" uniqKey="Inghilleri M" first="Maurizio" last="Inghilleri">Maurizio Inghilleri</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS</s1>
<s2>Pozzilli, IS</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Rothwell, John C" sort="Rothwell, John C" uniqKey="Rothwell J" first="John C." last="Rothwell">John C. Rothwell</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0135498</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0135498 INIST</idno>
<idno type="RBID">Pascal:06-0135498</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C84</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001037</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections</title>
<author><name sortKey="Mir, Pablo" sort="Mir, Pablo" uniqKey="Mir P" first="Pablo" last="Mir">Pablo Mir</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Servicio de Neurología, Hospital Universitario Virgen del Rocio</s1>
<s2>Seville</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Gilio, Francesca" sort="Gilio, Francesca" uniqKey="Gilio F" first="Francesca" last="Gilio">Francesca Gilio</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS</s1>
<s2>Pozzilli, IS</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Edwards, Mark" sort="Edwards, Mark" uniqKey="Edwards M" first="Mark" last="Edwards">Mark Edwards</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Inghilleri, Maurizio" sort="Inghilleri, Maurizio" uniqKey="Inghilleri M" first="Maurizio" last="Inghilleri">Maurizio Inghilleri</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS</s1>
<s2>Pozzilli, IS</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Rothwell, John C" sort="Rothwell, John C" uniqKey="Rothwell J" first="John C." last="Rothwell">John C. Rothwell</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bontoxilysin</term>
<term>Excitability</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Palpebral reflex</term>
<term>Spasm</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Excitabilité</term>
<term>Homme</term>
<term>Spasme</term>
<term>Traitement</term>
<term>Bontoxilysin</term>
<term>Réflexe palpébral</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hemimasticatory spasm (HMS) is a condition characterized by paroxysmal involuntary contraction of masticatory muscles. We performed an electrophysiological investigation of a single patient with HMS to identify any pathophysiological changes associated with the condition. We identified a delayed M wave and jaw jerk on the affected side and an absent masseteric silent period during spasm. Botulinum toxin injections successfully treated the clinical symptoms and resulted in a significant reduction in the excitability of the blink reflex recovery cycle. These data suggest that HMS may be due to ectopic activity in the motor portion of the trigeminal nerve that is capable of inducing changes in the excitability of central reflex pathways. These changes can be altered by successful treatment with botulinum toxin.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>21</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MIR (Pablo)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GILIO (Francesca)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>EDWARDS (Mark)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>INGHILLERI (Maurizio)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BHATIA (Kailash P.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ROTHWELL (John C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>QUINN (Niall)</s1>
</fA11>
<fA14 i1="01"><s1>Sobell Department of Movement Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Servicio de Neurología, Hospital Universitario Virgen del Rocio</s1>
<s2>Seville</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurological Sciences, University of Rome La Sapienza, INM Neuromed IRCCS</s1>
<s2>Pozzilli, IS</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>73-78</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000133169150120</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>24 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0135498</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Hemimasticatory spasm (HMS) is a condition characterized by paroxysmal involuntary contraction of masticatory muscles. We performed an electrophysiological investigation of a single patient with HMS to identify any pathophysiological changes associated with the condition. We identified a delayed M wave and jaw jerk on the affected side and an absent masseteric silent period during spasm. Botulinum toxin injections successfully treated the clinical symptoms and resulted in a significant reduction in the excitability of the blink reflex recovery cycle. These data suggest that HMS may be due to ectopic activity in the motor portion of the trigeminal nerve that is capable of inducing changes in the excitability of central reflex pathways. These changes can be altered by successful treatment with botulinum toxin.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02C</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17F</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Excitabilité</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Excitability</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Excitabilidad</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Spasme</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Spasm</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Espasmo</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Traitement</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Treatment</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Réflexe palpébral</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Palpebral reflex</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Reflejo palpebral</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fN21><s1>086</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001037 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001037 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:06-0135498
   |texte=   Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections

Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri